ARCX vs VXUS
Tradr 2X Long ACHR Daily ETF vs Vanguard Total International Stock ETF
Which is better, ARCX or VXUS?
Trading-Leveraged Equity against Large Cap Blend.
VXUS has a lower expense ratio. VXUS led over 1Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | ARCX | VXUS |
|---|---|---|
| Expense Ratio | 1.30% | 0.05%Best |
| AUM | $7M | $158.1B |
| Dividend Yield | 0.00% | 2.51% |
| Holdings | 6 | 8,747 |
| YTD Return | -73.23% | +12.82%Best |
| 1Y Return | -83.75% | +19.86%Best |
| 3Y Return (annualized) | - | +19.33% |
| 5Y Return (annualized) | - | +9.46% |
| Volatility (annualized) | 109.0% | 13.2%Best |
| Max Drawdown | -94.3% | -11.3%Best |
| $10,000 over 1.3 years | $839 | $13,083Best |
| Fund Family | Tradr ETFs | Vanguard (US) |
| Category | Alternative | Equity |
| Style | Trading-Leveraged Equity | Large Cap Blend |
| Inception | Jun 9, 2025 | Jan 26, 2011 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 1.3 years row, are measured over the window both funds cover: Jun 10, 2025 to Sep 18, 2026 (1.3 years).
ARCX vs VXUS growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 1.3 years both funds cover.
ARCX vs VXUS Performance
Tradr 2X Long ACHR Daily ETF (ARCX) is an ETF from Tradr ETFs and Vanguard Total International Stock ETF (VXUS) is an ETF from Vanguard (US). Over the past year ARCX returned -83.75% while VXUS returned +19.86%. Year to date, ARCX is down 73.23% versus a gain of 12.82% for VXUS.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
ARCX has been the more volatile fund, with annualized monthly volatility of 109.0% compared with 13.2% for VXUS. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -94.3% for ARCX and -11.3% for VXUS. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.56. They move together some of the time, and apart the rest.
Fees and Cost Over Time
ARCX charges 1.30% per year while VXUS charges 0.05%. On a $10,000 position that is $130 vs $5 annually, a gap of $125 per year that compounds over a long holding period. On income, ARCX currently yields 0.00% against 2.51% for VXUS.
You are not choosing between two funds in isolation.
Whichever of ARCX and VXUS you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, ARCX or VXUS?
ARCX has an expense ratio of 1.30% while VXUS charges 0.05%. VXUS is the cheaper option, by $125 a year on a $10,000 investment.
Which performed better, ARCX or VXUS?
Over the past year ARCX returned -83.75% vs +19.86% for VXUS, so VXUS leads on 1-year performance. Over the longest common window we track (1 years), ARCX annualized -85.13% vs +22.96% for VXUS. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, ARCX or VXUS?
ARCX has been the more volatile fund at 109.0% annualized versus 13.2% for VXUS. Worst drawdown: ARCX -94.3% vs VXUS -11.3%.
Should I hold both ARCX and VXUS?
ARCX and VXUS have a monthly-return correlation of 0.56, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, ARCX or VXUS?
ARCX yields 0.00% while VXUS yields 2.51%, so VXUS currently pays the higher dividend yield.
Is VXUS better than ARCX?
VXUS has a lower expense ratio. VXUS led over 1Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.